Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

References

Page 1

	Year	Citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement David Moher, A. Liberati, Jennifer Tetzlaff, BMJ	2009	82.3K
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. David Moher, Alessandro Liberati, Jennifer Tetzlaff, PubMed Family MedicineCounselingSystematic Literature StudyClinical GuidelinesPrimary Care	2009	45.1K
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement David Moher, Alessandro Liberati, Jennifer Tetzlaff, Journal of Clinical Epidemiology CounselingFamily MedicineSystematic Literature StudyMeta-analysisHealth Policy	2009	19.6K
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation Larissa Shamseer, David Moher, Mike Clarke, BMJ	2015	12.6K
Developing and evaluating complex interventions: the new Medical Research Council guidance Peter Craig, Paul Dieppe, Sally MacIntyre, BMJ	2008	10.9K
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman, Annals of Internal Medicine Clinical EndpointTrial ProtocolsClinical GuidelinesProtocol ComplianceClinical Trials	2013	7.4K
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials A.-W. Chan, Jennifer Tetzlaff, Peter C Gøtzsche, BMJ Spirit StatementHealth PolicyClinical Trial ManagementHigh Quality ProtocolsPatient Safety	2013	6.6K
Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials An‐Wen Chan, Asbjørn Hróbjartsson, Mette T. Haahr, JAMA	2004	1.8K
A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts Elliott M. Antman JAMA	1992	1.5K
Guidance for Developers of Health Research Reporting Guidelines David Moher, Kenneth F. Schulz, Iveta Simera, PLoS Medicine Preventive MedicineHealth PolicyClinical EffectivenessDavid MoherGlobal Health	2010	1.4K

Page 1